Tgf Beta1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
[^1]
[^2]
[^3]
Protein Name: Transforming Growth Factor Beta-1
[^4]
Gene: TGFB1
[^5]
UniProt ID: P01137
[^6]
PDB Structure IDs: 1KLC, 3KCF
[^7]
Molecular Weight: ~12.8 kDa (latent complex ~90 kDa)
Subcellular Localization: Secreted (latent complex stored in ECM)
Protein Family: TGF-beta family
TGF-beta1 is synthesized as a precursor that forms a latent complex with latency-associated peptide (LAP). The active dimer (12.8 kDa per monomer) is released by proteolytic cleavage or conformational change. Each monomer contains nine conserved cystines forming disulfide bonds.
TGF-beta1 has diverse biological activities:
- Neuroprotection and neurotrophic effects
- Regulation of synaptic plasticity
- Anti-inflammatory effects on microglia
- Promotion of astrocyte reactivity
- Regulation of blood-brain barrier integrity
- Alzheimer's Disease: Elevated TGF-beta1 in AD brains. Promotes amyloid accumulation but also has neuroprotective effects. The balance is critical.
- Parkinson's Disease: TGF-beta1 protects dopaminergic neurons; reduced signaling may contribute to degeneration.
- Multiple Sclerosis: TGF-beta1 deficiency worsens disease; therapeutic potential for boosting signaling.
- Stroke: TGF-beta1 is upregulated after ischemia and contributes to repair.
- TGF-beta1 Agonists: Being explored for neuroprotection
- TGF-beta1 Antagonists: Used in some cancer therapies; unclear benefit for neurodegeneration
- Smad-dependent signaling modulators: Downstream pathway targets
- Roberts AB, et al. (1990). "TGF-beta: role in disease." Ann NY Acad Sci. 593:1-6. PMID:2141741
- Zhu Y, et al. (2002). "TGF-beta signaling in neural development." Cell. 111(2):251-263. PMID:12419245
Transforming Growth Factor Beta 1 (TGF-beta1) is a protein involved in neuroinflammation, immune regulation, and neurodegenerative diseases. It plays critical roles in cell signaling, immune response, and disease pathogenesis.
The study of Tgf Beta1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.